Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study

Publisher： Karger

E-ISSN： 1421-9832|212|2|137-144

ISSN： 1018-8665

Source： Dermatology, Vol.212, Iss.2, 2006-03, pp. : 137-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness of Biological Therapy in Remission Induction of Moderate to Severe Plaque Psoriasis

By  

Dermatology, Vol. 221, Iss. 3, 2010-10 ,pp. : 236-242

Karger

Access to resources Recommend Favorite

Cost-Effectiveness Model of Topical Treatment of Mild to Moderate Psoriasis Vulgaris in Germany

By  

Dermatology, Vol. 215, Iss. 3, 2007-09 ,pp. : 219-228

Karger

Access to resources Recommend Favorite

Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany

By  

Dermatology, Vol. 216, Iss. 4, 2008-03 ,pp. : 366-372

Karger

Access to resources Recommend Favorite

Mild Cognitive Impairment in Patients with Moderate to Severe Chronic Plaque Psoriasis

By  

Dermatology, Vol. 228, Iss. 1, 2014-01 ,pp. : 78-85

Karger

Access to resources Recommend Favorite

Patients with Moderate to Severe Plaque Psoriasis: One Year after the European Medicines Agency Recommendation of Efalizumab Suspension

By  

Dermatology, Vol. 222, Iss. 3, 2011-04 ,pp. : 250-255

Karger

Access to resources Recommend Favorite